Asia Pacific Clinical Trials Supplies Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Asia Pacific Clinical Trials Supplies Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Asia Pacific Clinical Trials Supplies Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Asia Pacific Clinical Trials Supplies Market Regional Analysis

6.2 Asia Pacific Clinical Trials Supplies Market Revenue 2017-2027 (US$ Million)

6.3 Asia Pacific Clinical Trials Supplies Market Forecast Analysis

7. Asia Pacific Clinical Trials Supplies Market Analysis – by Product & Service

7.1 Manufacturing

7.1.1 Overview
7.1.2 Manufacturing: Asia Pacific Clinical Trials Supplies Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.2 Packaging & Labelling

7.2.1 Overview
7.2.2 Packaging & Labelling: Asia Pacific Clinical Trials Supplies Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.3 Logistics & Distribution

7.3.1 Overview
7.3.2 Logistics & Distribution: Asia Pacific Clinical Trials Supplies Market – Revenue and Forecast, 2017-2027 (US$ Million)

8. Asia Pacific Clinical Trials Supplies Market Analysis – by Stage

8.1 Phase I

8.1.1 Overview
8.1.2 Phase I: Asia Pacific Clinical Trials Supplies Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.2 Phase II

8.2.1 Overview
8.2.2 Phase II: Asia Pacific Clinical Trials Supplies Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.3 Phase III

8.3.1 Overview
8.3.2 Phase III: Asia Pacific Clinical Trials Supplies Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.4 Bioequivalence Studies

8.4.1 Overview
8.4.2 Bioequivalence Studies: Asia Pacific Clinical Trials Supplies Market – Revenue and Forecast, 2017-2027 (US$ Million)

9. Asia Pacific Clinical Trials Supplies Market Analysis – by Drug Type

9.1 Small-Molecule Drugs

9.1.1 Overview
9.1.2 Small-Molecule Drugs: Asia Pacific Clinical Trials Supplies Market – Revenue and Forecast, 2017-2027 (US$ Million)

9.2 Biologic Drugs

9.2.1 Overview
9.2.2 Biologic Drugs: Asia Pacific Clinical Trials Supplies Market – Revenue and Forecast, 2017-2027 (US$ Million)

10. Asia Pacific Clinical Trials Supplies Market Analysis – by Application

10.1 Oncology

10.1.1 Overview
10.1.2 Oncology: Asia Pacific Clinical Trials Supplies Market – Revenue and Forecast, 2017-2027 (US$ Million)

10.2 Cardiovascular Diseases

10.2.1 Overview
10.2.2 Cardiovascular Diseases: Asia Pacific Clinical Trials Supplies Market – Revenue and Forecast, 2017-2027 (US$ Million)

10.3 Neurological Disorders

10.3.1 Overview
10.3.2 Neurological Disorders: Asia Pacific Clinical Trials Supplies Market – Revenue and Forecast, 2017-2027 (US$ Million)

10.4 Respiratory Disorders

10.4.1 Overview
10.4.2 Respiratory Disorders: Asia Pacific Clinical Trials Supplies Market – Revenue and Forecast, 2017-2027 (US$ Million)

11. Asia Pacific Clinical Trials Supplies Market – Asia-Pacific Analysis

11.1 Overview

11.2 Asia-Pacific

11.2.1 Asia Pacific Clinical Trials Supplies Market Breakdown, by Key Country, 2020 and 2027 (%)
11.2.1.1 Asia Pacific Clinical Trials Supplies Market – Revenue and Forecast Analysis – by Country
11.2.1.1 China: Asia Pacific Clinical Trials Supplies Market – Revenue and Forecast to 2027 (US$ Million)

11.2.1.1.1 China: Asia Pacific Clinical Trials Supplies Market Breakdown, by Product & Service
11.2.1.1.2 China: Asia Pacific Clinical Trials Supplies Market Breakdown, by Stage
11.2.1.1.3 China: Asia Pacific Clinical Trials Supplies Market Breakdown, by Drug Type
11.2.1.1.4 China: Asia Pacific Clinical Trials Supplies Market Breakdown, by Application

11.2.1.2 India: Asia Pacific Clinical Trials Supplies Market – Revenue and Forecast to 2027 (US$ Million)

11.2.1.2.1 India: Asia Pacific Clinical Trials Supplies Market Breakdown, by Product & Service
11.2.1.2.2 India: Asia Pacific Clinical Trials Supplies Market Breakdown, by Stage
11.2.1.2.3 India: Asia Pacific Clinical Trials Supplies Market Breakdown, by Drug Type
11.2.1.2.4 India: Asia Pacific Clinical Trials Supplies Market Breakdown, by Application

11.2.1.3 Japan: Asia Pacific Clinical Trials Supplies Market – Revenue and Forecast to 2027 (US$ Million)

11.2.1.3.1 Japan: Asia Pacific Clinical Trials Supplies Market Breakdown, by Product & Service
11.2.1.3.2 Japan: Asia Pacific Clinical Trials Supplies Market Breakdown, by Stage
11.2.1.3.3 Japan: Asia Pacific Clinical Trials Supplies Market Breakdown, by Drug Type
11.2.1.3.4 Japan: Asia Pacific Clinical Trials Supplies Market Breakdown, by Application

11.2.1.4 Australia: Asia Pacific Clinical Trials Supplies Market – Revenue and Forecast to 2027 (US$ Million)

11.2.1.4.1 Australia: Asia Pacific Clinical Trials Supplies Market Breakdown, by Product & Service
11.2.1.4.2 Australia: Asia Pacific Clinical Trials Supplies Market Breakdown, by Stage
11.2.1.4.3 Australia: Asia Pacific Clinical Trials Supplies Market Breakdown, by Drug Type
11.2.1.4.4 Australia: Asia Pacific Clinical Trials Supplies Market Breakdown, by Application

11.2.1.5 Rest of Asia-Pacific : Asia Pacific Clinical Trials Supplies Market – Revenue and Forecast to 2027 (US$ Million)

11.2.1.5.1 Rest of Asia-Pacific : Asia Pacific Clinical Trials Supplies Market Breakdown, by Product & Service
11.2.1.5.2 Rest of Asia-Pacific : Asia Pacific Clinical Trials Supplies Market Breakdown, by Stage
11.2.1.5.3 Rest of Asia-Pacific : Asia Pacific Clinical Trials Supplies Market Breakdown, by Drug Type
11.2.1.5.4 Rest of Asia-Pacific : Asia Pacific Clinical Trials Supplies Market Breakdown, by Application

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 THERMO FISHER SCIENTIFIC INC.

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 UDG Healthcare plc

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Catalent Inc.

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 pci Pharma Services

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Almac Group

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 PAREXEL INTERNATIONAL CORPORATION

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Biocair

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Owens & Minor Inc

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Rubicon Research Pvt. Ltd

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

Asia Pacific Clinical Trials Supplies Market